Featured Stories
White House Fact Sheet: Restoring Trust in the Smithsonian
WASHINGTON, July 25 -- The White House issued the following fact sheet on July 24, 2026:
* * *
President Donald J. Trump Restores Trust in the Smithsonian Institution
RESTORING TRUST IN THE SMITHSONIAN: Today, President Donald J. Trump signed an Executive Order to reestablish confidence in the Smithsonian Institution. As illustrated by the Domestic Policy Council's report, Saving America's Story: How Ideological Capture at the Smithsonian Institution's National Museum of American History Erases Our Heritage (Report), the Smithsonian is failing to tell America's story with honesty, seriousness,
... Show Full Article
WASHINGTON, July 25 -- The White House issued the following fact sheet on July 24, 2026:
* * *
President Donald J. Trump Restores Trust in the Smithsonian Institution
RESTORING TRUST IN THE SMITHSONIAN: Today, President Donald J. Trump signed an Executive Order to reestablish confidence in the Smithsonian Institution. As illustrated by the Domestic Policy Council's report, Saving America's Story: How Ideological Capture at the Smithsonian Institution's National Museum of American History Erases Our Heritage (Report), the Smithsonian is failing to tell America's story with honesty, seriousness,and pride.
* The Order directs the Secretary of the Interior, the Director of the Office of Management and Budget, the Administrator of General Services, and the Assistant to the President for Domestic Policy to restore trust in the Smithsonian Institution by utilizing all available authorities to encourage it to correct the issues found in the Report and to comply with existing laws, funding requirements, and contract conditions.
* The Order directs the Secretary of the Interior to install temporary signage near the Museum, informing visitors of the findings of the Report and directing visitors to accurate information regarding America's history.
* The Order directs the Secretary of the Interior to install temporary exhibits or signage for the public that corrects inaccurate information presented in the National Museum of American History to ensure America's Founders are honored during its 250th year.
SAVING AMERICA'S STORY FROM CORROSIVE IDEOLOGY: In the last decade, Americans have witnessed a concerted effort to rewrite American history and force our Nation to adopt a factually baseless ideology aimed at discrediting American heroes and diminishing American achievement.
* The Domestic Policy Council's Report conclusively shows that Smithsonian and Museum leadership have directed the Museum's mission away from historical education and scholarship of a shared national inheritance to be celebrated, and toward extreme political activism, rooted in Marxism, to divide, dispirit, and discourage Americans.
* The Report demonstrates that the Smithsonian cannot be trusted to tell America's story honestly and is therefore not properly stewarding the over $1 billion entrusted to it by the American taxpayer each year.
* President Trump is fighting back to restore one of the Nation's greatest civic treasures to its founding mission and purpose and reestablish truth in the Nation's historical narrative.
CELEBRATING OUR HERITAGE: President Trump is committed to ensuring that American history is celebrated accurately, fairly, and with pride--honoring the remarkable progress, liberty, and ingenuity that define our great Nation.
* On his first day in office, President Trump signed an Executive Order to establish a task force to prepare for America's 250th birthday, inspire a renewed love for American history, encourage citizens to experience the beauty of our country, ignite a spirit of innovation to help our nation succeed for the next 250 years, and invite Americans to pray for our country.
- The task force launched numerous once-in-a-generation events for all Americans to celebrate their Nation's 250th birthday such as Rededicate 250, The Great American State Fair, Teddy Roosevelt Presidential Library Opening, International Naval Review & Sail 4th, Salute to America, and the Patriot Games Competition.
- This Order also protected America's monuments from vandalism and called for the construction of the National Garden of American Heroes.
* In March 2025, President Trump signed an Executive Order to restore truth and sanity to American history by revitalizing key cultural institutions and reversing the spread of divisive ideology.
* In March 2025, President Trump signed an Executive Order to make Washington, D.C. what it should be--the pride of every American to whom it belongs and established the D.C. Safe and Beautiful Task Force to restore and beautify monuments, statues, memorials, and parks.
- To celebrate America's 250th anniversary, the task force installed a series of statues at Freedom Plaza, honoring the heroes and martyrs of the American Revolution.
* In August 2025, President Trump signed an Executive Order to restore respect, pride, and sanctity to the American flag and prosecute those who desecrate this symbol of our freedom, identity, and strength to the fullest extent of the law.
* * *
Original text here: https://www.whitehouse.gov/fact-sheets/2026/07/fact-sheet-president-donald-j-trump-restores-trust-in-the-smithsonian-institution/
SEC Obtains Final Judgment Against Mexico-Based Company, Its CEO, 4 Individuals in Alleged Ponzi Scheme Targeting Spanish-Speaking U.S. Investors
WASHINGTON, July 25 -- The Securities and Exchange Commission issued the following litigation release (No. 3:23-cv-00353; W.D. Tex. filed Sept. 21, 2023):
* * *
Securities and Exchange Commission v. Aras Investment Business Group S.A.P.I. de C.V. et. al, No. 3:23-cv-00353 (W.D. Tex. filed Sept. 21, 2023)
On July 13, 2026, the U.S. District Court for the Western District of Texas entered a final judgment as to Aras Investment Business Group S.A.P.I. de C.V., its CEO Armando Gutierrez Rosas, and four individuals in connection with an alleged fraudulent scheme that raised millions from retail investors
... Show Full Article
WASHINGTON, July 25 -- The Securities and Exchange Commission issued the following litigation release (No. 3:23-cv-00353; W.D. Tex. filed Sept. 21, 2023):
* * *
Securities and Exchange Commission v. Aras Investment Business Group S.A.P.I. de C.V. et. al, No. 3:23-cv-00353 (W.D. Tex. filed Sept. 21, 2023)
On July 13, 2026, the U.S. District Court for the Western District of Texas entered a final judgment as to Aras Investment Business Group S.A.P.I. de C.V., its CEO Armando Gutierrez Rosas, and four individuals in connection with an alleged fraudulent scheme that raised millions from retail investorsin the U.S., most of whom were members of the Mexican American community.
The SEC's complaint, filed on September 21, 2023, alleged that, from about March 2020 through November 2021, Gutierrez raised money from investors for the purported purpose of investing in U.S. real estate and mining operations in Mexico, promising investors monthly returns as high as 10 percent. According to the complaint, no investor funds were used for investment purposes; instead, Gutierrez was operating a Ponzi scheme and affinity fraud and used investor funds to pay for his personal expenses including a $2.5 million mansion in Texas.
The SEC charged Aras and Gutierrez with violating Sections 5 and 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934and Rule 10b-5 thereunder. It also charged Gutierrez with control person liability under Section 20(a) of the Exchange Act and charged the four individuals with various violations of the federal securities laws, including aiding and abetting Aras's and Gutierrez's violations of the antifraud provisions.
On September 25, 2023, the Court entered consent judgments as to the four individuals, which enjoined them from future violations of the charged provisions. On November 5, 2025, the Court entered a default judgment as to liability against Aras and Gutierrez.
The final judgment ordered the defendants liable for disgorgement with prejudgment interest in the following amounts: $448,746 and $129,614 against Aras and Gutierrez, respectively, on a joint and several basis; $1,256,372 against Maria de Lourdes Tolentino Roque; $242,080 against Diayanira Rendon Trejo; $313,985 against Efren Quiroz Gardea; and $139,542 against Luis Quiroz Gardea. The Court also ordered Gutierrez to pay a civil penalty of $448,746.
The SEC's litigation was led by Kristen Warden and was supervised by Melissa Armstrong and Tim England.
* * *
Resources
* Final Judgment (https://www.sec.gov/files/litigation/litreleases/2026/judg26595.pdf)
* * *
Original text here: https://www.sec.gov/enforcement-litigation/litigation-releases/lr-26595
President Trump Issues Executive Order on Restoring Trust in the Smithsonian Institution
WASHINGTON, July 25 -- President Trump issued the following executive order on July 24, 2026:
* * *
RESTORING TRUST IN THE SMITHSONIAN INSTITUTION
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered:
Section 1. Policy. On March 27, 2025, I issued Executive Order 14253 (Restoring Truth and Sanity to American History). Pursuant to that order, the Domestic Policy Council recently completed a months-long review of the Smithsonian Institution and its National Museum of American History (Museum) and issued its findings
... Show Full Article
WASHINGTON, July 25 -- President Trump issued the following executive order on July 24, 2026:
* * *
RESTORING TRUST IN THE SMITHSONIAN INSTITUTION
By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered:
Section 1. Policy. On March 27, 2025, I issued Executive Order 14253 (Restoring Truth and Sanity to American History). Pursuant to that order, the Domestic Policy Council recently completed a months-long review of the Smithsonian Institution and its National Museum of American History (Museum) and issued its findingsin the report entitled Saving America's Story: How Ideological Capture at the Smithsonian Institution's National Museum of American History Erases Our Heritage (Report).
The Report demonstrates that the Smithsonian leadership does not present American history as a shared national inheritance to be taught and celebrated, but instead views American history as a "prime tool" to advance ideas of social justice and the radical transformation of our society. The Report also overwhelmingly demonstrates that current leadership of both the Smithsonian Institution and the Museum cannot be trusted to tell America's story with honesty and gratitude.
It is therefore the policy of my Administration to take all available steps to ensure that the issues identified in the Report are addressed and to restore trust in the Smithsonian Institution.
Sec. 2. Restoring Trust in the Smithsonian Institution. The Secretary of the Interior, the Director of the Office of Management and Budget, the Administrator of General Services, and the Assistant to the President for Domestic Policy shall identify and utilize any and all available authorities to promote the policy of this order and to restore trust in the Smithsonian Institution, including any mechanisms available to encourage correction of the issues identified in the Report and compliance with any applicable statutes, regulations, executive actions, and funding or contract conditions.
Sec. 3. Warning Visitors About the Ideological Capture at the National Museum of American History. (a) The Secretary of the Interior, acting through the Director of the National Park Service (NPS) and in coordination with the Assistant to the President for Domestic Policy, shall install temporary signage along the NPS-maintained sidewalks and walkways used by the public to access the Museum, informing visitors of the findings of the Report and of the policy set forth in section 1 of this order. Such signage shall notify visitors that the Museum exhibits should be renovated consistent with the findings in the Report and direct visitors to locations and resources for accurate information regarding America's history.
(b) Because the Museum has failed to appropriately honor the 56 signers of the Declaration of Independence during this 250th anniversary year of the founding of our country, the Secretary of the Interior, acting through the Director of the NPS and in coordination with the Assistant to the President for Domestic Policy, shall install temporary exhibits or signage on NPS-maintained sidewalks, walkways, and land used by the public that corrects inaccurate information presented in the Museum.
Sec. 4. General Provisions. (a) Nothing in this order shall be construed to impair or otherwise affect:
(i) the authority granted by law to an executive department or agency, or the head thereof; or
(ii) the functions of the Director of the Office of Management and Budget relating to budgetary, administrative, or legislative proposals.
(b) This order shall be implemented consistent with applicable law and subject to the availability of appropriations.
(c) This order is not intended to, and does not, create any right or benefit, substantive or procedural, enforceable at law or in equity by any party against the United States, its departments, agencies, or entities, its officers, employees, or agents, or any other person.
(d) The costs for publication of this order shall be borne by the Department of the Interior.
DONALD J. TRUMP
* * *
Original text here: https://www.whitehouse.gov/presidential-actions/2026/07/restoring-trust-in-the-smithsonian-institution-e061/
NIH Selects Dr. Courtney Aklin as Director of the National Institute of Nursing Research
WASHINGTON, July 25 -- The U.S. Department of Health and Human Services National Institutes of Health issued the following news release on July 24, 2026:
* * *
NIH selects Dr. Courtney Aklin as director of the National Institute of Nursing Research
National Institutes of Health (NIH) Director Jay Bhattacharya, M.D., Ph.D., today announced the selection of Courtney F. Aklin, Ph.D., as director of NIH's National Institute of Nursing Research (NINR). Dr. Aklin is currently the Acting Director and Acting Scientific Director at NINR, positions she has held since April 2025. In these roles, she has
... Show Full Article
WASHINGTON, July 25 -- The U.S. Department of Health and Human Services National Institutes of Health issued the following news release on July 24, 2026:
* * *
NIH selects Dr. Courtney Aklin as director of the National Institute of Nursing Research
National Institutes of Health (NIH) Director Jay Bhattacharya, M.D., Ph.D., today announced the selection of Courtney F. Aklin, Ph.D., as director of NIH's National Institute of Nursing Research (NINR). Dr. Aklin is currently the Acting Director and Acting Scientific Director at NINR, positions she has held since April 2025. In these roles, she hasled the NINR's scientific and organizational strategy, strengthened NIH-wide collaborations and advanced research priorities that position nursing science to address complex health challenges. She is expected to begin her permanent role as the NINR director on July 26, 2026.
"Nursing science plays a vital role in improving health outcomes for patients and families at every stage of life," said Dr. Bhattacharya. "Dr. Aklin has spent more than two decades at NIH, and for more than a year, has effectively led NINR as Acting Director. She knows this Institute, she knows its people, and she knows the science. I'm confident she will be an outstanding director for NINR."
As NINR director, Dr. Aklin will oversee NINR's annual budget of nearly $200 million, the majority of which supports extramural research at institutions across the United States. NINR researchers and supported science teams conduct rigorous, solutions-oriented research to address pressing health challenges, improve care delivery, and inform practice. The Institute's extramural and intramural research programs advance science across a range of real-world settings and populations, including research focused on conditions of daily life, the distribution of health and disease, disease prevention and management, and systems and settings of care. Across these programs, NINR also invests in research training and career development to prepare the next generation of nurse scientists.
Dr. Aklin has more than 21 years of scientific, strategic, and executive leadership experience at NIH, with a career dedicated to advancing biomedical research, strengthening scientific organizations, and accelerating the translation of evidence into improved health. Prior to assuming her current roles at NINR, Dr. Aklin served as the NINR Deputy Director beginning in September 2023. She additionally served as Acting Associate Deputy Director of NIH from December 2021 to September 2023 and was also a senior advisor within the Immediate Office of the Director (IMOD), where she advised NIH leadership on complex scientific and organizational priorities, enterprise strategy, and high-impact initiatives supporting the effective operation of IMOD. She also previously served as the Chief of Staff at the National Institute on Minority Health and Health Disparities.
At the National Institute on Neurological Disorders and Stroke, Dr. Aklin led programs that expanded research capacity and strengthened the biomedical workforce by supporting the development of emerging neuroscience research programs at universities and medical schools. Prior to her work at NINDS, she managed and advanced the fear and anxiety research portfolio at the National Institute of Mental Health. She came to NIH in 2004 as an American Association for the Advancement of Sciences Science and Technology Policy Fellow to work on activities related to the Interagency Autism Coordinating Committee.
Dr. Aklin is a licensed clinical psychologist whose expertise spans behavioral, translational, and implantation science. She earned a Ph.D. in clinical psychology from the University of Maryland, College Park, and a B.A. in business administration and psychology from the University of Richmond.
* * *
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH...Turning Discovery Into Health(R)
* * *
Original text here: https://www.nih.gov/news-events/news-releases/nih-selects-dr-courtney-aklin-director-national-institute-nursing-research
NIH Announces Winners of S-Index Challenge to Advance Data Sharing Across Biomedical Research
BETHESDA, Maryland, July 25 -- The National Eye Institute issued the following news:
* * *
NIH announces winners of S-index Challenge to advance data sharing across biomedical research
Prize competition winners reveal approaches to a metric to measure, reward sharing of high-quality data
Bioinformatics Basic Research Clinical Research Translational Research NEI
-
In the 21st century, biomedical science is increasingly based on "big data". The National Institutes of Health (NIH) is aiming to ensure that researchers who generate and share high-quality datasets receive recognition. The NIH Data
... Show Full Article
BETHESDA, Maryland, July 25 -- The National Eye Institute issued the following news:
* * *
NIH announces winners of S-index Challenge to advance data sharing across biomedical research
Prize competition winners reveal approaches to a metric to measure, reward sharing of high-quality data
Bioinformatics Basic Research Clinical Research Translational Research NEI
-
In the 21st century, biomedical science is increasingly based on "big data". The National Institutes of Health (NIH) is aiming to ensure that researchers who generate and share high-quality datasets receive recognition. The NIH DataSharing Index, or S-index, is envisioned as a new metric that measures how effectively researchers make scientific data available for others to find, access, reuse, and build upon.
The NIH S-index Challenge, a $1million prize competition, invited innovators to develop and validate approaches for measuring the scientific impact of data sharing while also emphasizing FAIR (Findable, Accessible, Interoperable, and Reusable) data practices and real-world research impact.
The scientific community has traditionally measured a researcher's impact by their publication record, often using the h-index, which reflects the productivity and influence of their scholarly work. While individual papers typically advance science incrementally, shared datasets can enable many future discoveries by supporting hypothesis generation and results validation. Inspired by the h-index, the S-index recognizes the scientific impact of creating and sharing high-quality datasets that serve as foundational resources for the research community.
"By rewarding high-quality data sharing, beyond simply data generation, the S-index aims to accelerate discovery and foster a culture in which data sharing and team science are recognized as meaningful scientific contributions," said Michael F. Chiang, M.D., director of the National Eye Institute, which led the challenge on behalf of NIH.
"Recognizing a new S-index metric is just the beginning and part of a broader NIH effort to strengthen rigor, reproducibility and transparency of science," Chiang said. The finalist teams developed innovative and complimentary approaches to measuring and rewarding high-quality data sharing, providing a foundation for the continued evolution of the S-index and future collaboration across the research community.
Beyond announcing the winners, the S-index Innovation Event convened leaders from academia, publishing, government, and the broader research community to discuss implementation strategies, adoption pathways, and the cultural changes needed to recognize data sharing as a core scholarly contribution.
Seven finalist teams advanced to a live judging session at NIH, where they presented and demonstrated their S-index models before a panel of senior NIH leaders. Final selections reflected the live presentations as well as evaluations conducted over the past several months by independent subject matter experts outside the federal government and a federal judging panel. The final winners were:
First Place ($400,000)
Project: A simple and field-aware S-index for promoting and rewarding data sharing in which the team developed Scholar Data (scholardata.io), a platform inspired by Google Scholar that measures the scientific impact of shared datasets.
Lead: Bhavesh Patel, Ph.D. (California Medical Innovations Institute)
Team: Aaron Lee, M.D. and Cecilia Lee, M.D., (Washington University St. Louis), Sanjay Soundarajan, Ph.D., James O'Neill, Ph.D., and Aydan Gasimova, Ph.D. (California Medical Innovations Institute)
Second Place ($300,000)
Project: The SHARE Index: a unified metric for recognizing exemplary data sharing behavior
Lead: Shuhan He, M.D. (Harvard Medical School; ConductScience)
Team: Yijian Henry He, Ph.D., Lawrence Jiang, Bifei Hao, Boyu Peng and Santosh Adhikari (ConductScience), Allison Goff, Ph.D., Shivani Pimparkar and Pedram Safari, Ph.D. (MGH Institute of Health Professions), Joshua Goldstein, M.D., Ph.D. (Harvard Medical School), Andrew Marshall, M.D. (Google), David Liebovitz, M.D. (Northwestern)
Third Place ($150,000)
Project: Engaging key stakeholder communities to promote data sharing and reuse, and to understand impact through a composite S-index
Lead: Griffin Weber, M.D., Ph.D. (Beth Israel Deaconess Medical Center).
Team: Katy Borner, Ph.D. (Indiana University), Amy Brand, Ph.D. (MIT), Kristi Holmes, Ph.D. (Northwestern), Daniel Hook, Ph.D. (Digital Science), John Inglis, Ph.D. (bioRxiv, medRxiv), Chonnettia Jones, Ph.D. (Addgene), Arjun Krishnan, Ph.D. (University of Colorado Anschutz), and Steinn Sigurdsson, Ph.D. (Penn State, arXiv).
Honorable Mention ($37,500)
Project: The S-Index: how many researchers has your data enabled?
Lead: Taom Sakal, Ph.D. (Great Ecology)
Team: Luke Sakal, (California State University, Chico)
NIH will continue working with stakeholders across the biomedical research community to explore opportunities for advancing the S-index and fostering a culture that recognizes and rewards high-quality data sharing.
To watch the NIH S-Index Innovation Event, go to the NIH Videocast (https://videocast.nih.gov/watch/b6faf831-70b8-11f1-82c0-124f0a52e769)
* * *
Original text here: https://www.nei.nih.gov/research-and-training/research-news/nih-announces-winners-s-index-challenge-advance-data-sharing-across-biomedical-research
Jimmy Carter National Historical Park Welcomes Karen Barry as Superintendent
WASHINGTON, July 25 -- The U.S. Department of the Interior National Park Service issued the following news release:
* * *
Jimmy Carter National Historical Park Welcomes Karen Barry as Superintendent
PLAINS, Ga. -- The National Park Service has selected Karen Barry as the new Superintendent of Jimmy Carter National Historical Park. Barry has served as the park's Acting Superintendent for the past year and brings more than two decades of experience, regional leadership and a deep personal connection to the Plains community. She will begin her official role as Superintendent on Aug. 9.
"It is
... Show Full Article
WASHINGTON, July 25 -- The U.S. Department of the Interior National Park Service issued the following news release:
* * *
Jimmy Carter National Historical Park Welcomes Karen Barry as Superintendent
PLAINS, Ga. -- The National Park Service has selected Karen Barry as the new Superintendent of Jimmy Carter National Historical Park. Barry has served as the park's Acting Superintendent for the past year and brings more than two decades of experience, regional leadership and a deep personal connection to the Plains community. She will begin her official role as Superintendent on Aug. 9.
"It isboth humbling and inspiring to lead the park as we transition from sharing the story of a living President and First Lady to preserving a legacy that will endure for generations," said Superintendent Karen Barry. "Together with the Carter family, our community, partners and stakeholders, we will honor their lives of service and ensure that visitors continue to find inspiration in the places and values that shaped them."
Barry has worked for 21 years as an Administrative Officer at Jimmy Carter National Historical Park. She has worked as an Administrative Officer at Andersonville National Historic Site since 2013 and Ocmulgee Mounds National Historical Park since 2018. She currently serves on the Southeast Regional Administrative Advisory Committee and as co-chair of the Georgia/Northeast Florida Administrative Officer Team.
Throughout her career, Barry has played a critical role in major milestones across both parks, including the rehabilitation and opening of Plains High School in 1996, the dedication of the Depot in 1997, the opening of the National Prisoner of War Museum in 1998 and the rehabilitation and opening of President Carter's Boyhood Home in 2000.
During Barry's tenure as Acting Superintendent, the park opened the Carter Gardens to the public for the first time in July 2025.
Born and raised in Macon, Ga., Barry joined the NPS after passing the Andersonville National Historic Site daily and feeling inspired to inquire about vacancies. In her free time, Barry enjoys thrifting, watching high school and college sports and spending time with her husband, Chris; her sons Benjamin and Will; daughter-in-law, Grace; and granddaughter Collins.
* * *
Original text here: https://www.nps.gov/jica/learn/news/2026-07-24-karen-barry-superintendent.htm
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION
WASHINGTON, July 25 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:
* * *
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION
Summary
Company Announcement Date: July 24, 2026
FDA Publish Date: July 24, 2026
Product Type: Drugs
Reason for Announcement: Particulate matter (cardboard) found in the solution.
Company Name: Baxter International Inc.
Brand Name: Baxter
Product Description: Cefazolin
... Show Full Article
WASHINGTON, July 25 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:
* * *
BAXTER ISSUES VOLUNTARY NATIONWIDE RECALL OF CEFAZOLIN IN DEXTROSE INJECTION, USP, 2G / 100ML (20MG / ML) SINGLE-DOSE INFUSION BAG IN 100ML DUE TO PARTICULATE MATTER FOUND IN SOLUTION
Summary
Company Announcement Date: July 24, 2026
FDA Publish Date: July 24, 2026
Product Type: Drugs
Reason for Announcement: Particulate matter (cardboard) found in the solution.
Company Name: Baxter International Inc.
Brand Name: Baxter
Product Description: Cefazolinin Dextrose Injection
Company Announcement
DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.
Risk Statement: The use of the defective product has a reasonable probability of causing pulmonary emboli (blockage in pulmonary blood vessels), occlusions of other blood vessels (which can lead to tissue death and possible organ damage), and/or phlebitis (inflammation of the walls of veins, which may lead to clotting). Systemically, foreign particles infused intravenously can cause systemic activation of the immune system, organ dysfunction, and hemolysis (breakdown of blood cells). To date, Baxter has not received any reports of adverse events related to this issue.
Affected Product:
This product is used intravenously to treat bacterial infections or prevent them during surgery
Product Code ... Product Description ... Lot Number ... Expiration Date ... NDC Number
2G3508 ... Cefazolin in Dextrose Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix ... LD175708 ... 14-Feb-2027 ... 0338-3508-41
The affected lots can be identified by locating the lot number and expiration date on the front of the product package and the label attached to the carton, as shown in the images below.
The impacted product was distributed from 3/25/2025 to 6/30/2025 in the United States.
Customers should immediately discontinue use of and return all affected units in accordance with their facility's process. Baxter is contacting customers with instructions on how to identify and return the impacted product.
For general questions regarding this communication, please contact Baxter Healthcare Center for Service at 888-229-0001 between the hours of 7:00 am and 6:00 pm Central Time, Monday through Friday.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
* Complete and submit the report Online: www.fda.gov/medwatch/report.htm
* Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
The United States Food and Drug Administration (FDA) has been notified of this action.
* * *
Original text here: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-voluntary-nationwide-recall-cefazolin-dextrose-injection-usp-2g-100ml-20mg-ml-single
